DK0592484T3 - Brusetablet - Google Patents
BrusetabletInfo
- Publication number
- DK0592484T3 DK0592484T3 DK92912980.7T DK92912980T DK0592484T3 DK 0592484 T3 DK0592484 T3 DK 0592484T3 DK 92912980 T DK92912980 T DK 92912980T DK 0592484 T3 DK0592484 T3 DK 0592484T3
- Authority
- DK
- Denmark
- Prior art keywords
- acid
- pct
- layer
- gas
- salt
- Prior art date
Links
- 239000007938 effervescent tablet Substances 0.000 title abstract 2
- 239000002253 acid Substances 0.000 abstract 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 6
- 150000003839 salts Chemical class 0.000 abstract 4
- 239000013078 crystal Substances 0.000 abstract 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- 150000007513 acids Chemical class 0.000 abstract 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 abstract 2
- 239000001630 malic acid Substances 0.000 abstract 2
- 235000011090 malic acid Nutrition 0.000 abstract 2
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 abstract 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract 1
- 150000008043 acidic salts Chemical class 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 abstract 1
- 235000018342 monosodium citrate Nutrition 0.000 abstract 1
- 239000002524 monosodium citrate Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000011975 tartaric acid Substances 0.000 abstract 1
- 235000002906 tartaric acid Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Preparation (AREA)
- General Preparation And Processing Of Foods (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Superconductors And Manufacturing Methods Therefor (AREA)
- Gas Separation By Absorption (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH194291 | 1991-07-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0592484T3 true DK0592484T3 (da) | 1995-06-12 |
Family
ID=4222201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92912980.7T DK0592484T3 (da) | 1991-07-01 | 1992-06-24 | Brusetablet |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5415870A (fr) |
| EP (1) | EP0592484B1 (fr) |
| JP (1) | JP3517233B2 (fr) |
| AT (1) | ATE117199T1 (fr) |
| CA (1) | CA2112663C (fr) |
| DE (1) | DE59201238D1 (fr) |
| DK (1) | DK0592484T3 (fr) |
| ES (1) | ES2053411T3 (fr) |
| WO (1) | WO1993000886A1 (fr) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4027927A1 (de) * | 1990-09-04 | 1992-03-05 | Bayer Ag | Brausekomponente und verfahren zu ihrer herstellung |
| US5503846A (en) * | 1993-03-17 | 1996-04-02 | Cima Labs, Inc. | Base coated acid particles and effervescent formulation incorporating same |
| ATE140621T1 (de) * | 1993-04-15 | 1996-08-15 | Gergely Gerhard | Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen wirkstoff, und verfahren zur herstellung |
| DE59408273D1 (de) * | 1993-09-07 | 1999-06-24 | Gergely Gerhard | Brausemischung mit Alkalisalzen oder Lysinaten saurer, unlöslicher oder schwer löslicher Wirkstoffe |
| DE670160T1 (de) * | 1994-03-01 | 1996-03-14 | Gergely, Gerhard, Dr., Wien | Ein Brausesystem und einen Arzneiwirkstoff enthaltendes granuläres Produkt bzw. Tablette sowie Verfahren zu deren Herstellung. |
| ES2136157T3 (es) * | 1994-03-01 | 1999-11-16 | Gerhard Gergely | Producto granular o comprimido que contiene un sistema efervescente y una sustancia farmaceutica activa, asi como un procedimiento para su preparacion. |
| IL112779A (en) * | 1994-03-01 | 1999-11-30 | Gergely Gerhard | Granular product or tablet containing an efferescent system and an active pharmaceutical substance and its preparation |
| US5824339A (en) * | 1995-09-08 | 1998-10-20 | Takeda Chemical Industries, Ltd | Effervescent composition and its production |
| US6974595B1 (en) * | 1996-05-17 | 2005-12-13 | Proethic Pharmaceuticals, Inc. | Pharmaceutical compositions based on Diclofenae |
| US6077539A (en) * | 1996-11-12 | 2000-06-20 | Pozen, Inc. | Treatment of migraine headache |
| US5728401A (en) * | 1997-04-16 | 1998-03-17 | Ranbaxy Laboratories, Ltd. | Effervescent ranitidine formulations |
| CN1203841C (zh) * | 1997-10-21 | 2005-06-01 | 杰哈德·盖尔盖伊 | 泡腾碱 |
| EP0911032B2 (fr) * | 1997-10-27 | 2004-09-01 | Dr. Gergely & Co. | Compositions effervescentes contenant des extraits végétaux |
| US6428770B1 (en) * | 1997-12-03 | 2002-08-06 | Kao Corporation | Solid preparation for oral hygiene |
| US6235311B1 (en) * | 1998-03-18 | 2001-05-22 | Bristol-Myers Squibb Company | Pharmaceutical composition containing a combination of a statin and aspirin and method |
| DE19814257A1 (de) | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Brauseformulierungen |
| DE59808063D1 (de) * | 1998-06-03 | 2003-05-28 | Gergely Dr & Co | Mit Alkali- bzw. Erdalkali-Ionen dotierte Zitronensäure |
| AT407111B (de) * | 1998-12-22 | 2000-12-27 | Gergely Dr & Co | Zucker- und/oder zuckeralkoholhältiges matrixmaterial und verfahren zu seiner herstellung |
| GB9909801D0 (en) * | 1999-04-28 | 1999-06-23 | Btg Int Ltd | Ultrasound detectable instrument |
| US6766753B2 (en) * | 2001-03-20 | 2004-07-27 | Hank E Pierson | Pre-feeder for a main sail |
| US7488496B2 (en) * | 2002-03-06 | 2009-02-10 | Christer Rosen | Effervescent compositions comprising bisphosphonates and methods related thereto |
| CA2495886C (fr) | 2002-03-06 | 2011-05-03 | Lifizz, Inc. | Compositions effervescentes contenant des bisphosphonates et methodes connexes |
| WO2004112584A2 (fr) * | 2003-06-20 | 2004-12-29 | Intrinsic Therapeutics, Inc. | Dispositif et procede de pose d'un implant a travers une imperfection annulaire d'un disque intervertebral |
| PL2037758T3 (pl) | 2006-07-12 | 2019-04-30 | Purac Biochem Bv | Cząstki klasy spożywczej powlekane częściowo zobojętnionym kwasem |
| US8431171B2 (en) * | 2006-07-12 | 2013-04-30 | Purac Biochem B.V. | Partially neutralized acid coated food-grade particles |
| US8778398B2 (en) | 2008-11-04 | 2014-07-15 | Jazz Pharmaceuticals, Inc. | Immediate release formulations and dosage forms of gamma-hydroxybutyrate |
| TR200900881A2 (tr) * | 2009-02-05 | 2010-08-23 | Bi̇lgi̇ç Mahmut | Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler |
| US20120076865A1 (en) | 2010-03-24 | 2012-03-29 | Jazz Pharmaceuticals, Inc. | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances |
| CA2798178C (fr) * | 2010-05-04 | 2017-06-13 | Jazz Pharmaceuticals, Inc. | Formulations a liberation immediate et formes pharmaceutiques de gamma-hydroxybutyrate |
| ES2716525T3 (es) * | 2010-12-06 | 2019-06-13 | Effrx Pharmaceuticals Sa | Formulaciones de bisfosfonatos efervescentes estables con características de solubilización rápida |
| WO2013115744A1 (fr) * | 2012-01-31 | 2013-08-08 | Mahmut Bilgic | Procédé de préparation de compositions pharmaceutiques (effervescentes) contenant un inhibiteur de l'apha-glucosidase (p. ex. voglibose et metformine) |
| WO2014065890A1 (fr) * | 2012-10-25 | 2014-05-01 | Otc Nutrition Llc | Compositions de complément minéral de calcium solide à dissolution rapide et procédé de préparation |
| JP5935172B2 (ja) * | 2013-01-22 | 2016-06-15 | 株式会社東洋新薬 | 発泡性皮膚外用剤 |
| US20150025025A1 (en) * | 2013-07-19 | 2015-01-22 | Ricky McCullough | Immuno-modulators for treating functional epithelial syndromes |
| JP6627485B2 (ja) * | 2015-01-28 | 2020-01-08 | ライオン株式会社 | ゲル組成物及びその製造方法 |
| US10398662B1 (en) | 2015-02-18 | 2019-09-03 | Jazz Pharma Ireland Limited | GHB formulation and method for its manufacture |
| US12186296B1 (en) | 2016-07-22 | 2025-01-07 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| UY37341A (es) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada |
| US12478604B1 (en) | 2016-07-22 | 2025-11-25 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US20180263936A1 (en) | 2017-03-17 | 2018-09-20 | Jazz Pharmaceuticals Ireland Limited | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
| EP3883549A1 (fr) | 2018-11-19 | 2021-09-29 | Jazz Pharmaceuticals Ireland Limited | Formulations de médicament résistant à l'alcool |
| BR112021013766A2 (pt) | 2019-03-01 | 2021-09-21 | Flamel Ireland Limited | Composições de gama-hidroxibutirato com farmacocinética melhorada no estado alimentado |
| JP2021014431A (ja) * | 2019-07-12 | 2021-02-12 | ライオン株式会社 | 粉体組成物、粉体組成物を含有する内服固形製剤及びその製造方法 |
| CN111184694A (zh) * | 2020-01-19 | 2020-05-22 | 广东青云山药业有限公司 | 一种口腔速溶颗粒的制备方法 |
| TW202139986A (zh) | 2020-02-21 | 2021-11-01 | 愛爾蘭商爵士製藥愛爾蘭有限責任公司 | 治療原發性嗜睡症之方法 |
| US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
| US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2211485A (en) * | 1940-08-13 | Effervescent acetyl salicylic acid | ||
| US3345265A (en) * | 1963-10-09 | 1967-10-03 | Kendall & Co | Multiple layer tablet with calcium salt central core separated from soluble fluoride outer coating |
| US3887700A (en) * | 1969-11-28 | 1975-06-03 | Aspro Nicholas Ltd | Analgesic formulations |
| US4127645A (en) * | 1976-05-21 | 1978-11-28 | Life Savers, Inc. | Effervescent tablet and method |
| AT374348B (de) * | 1980-07-01 | 1984-04-10 | Gergely Gerhard | Verfahren zur herstellung von gewuenschtenfalls zu brausetabletten verarbeitbaren brausegranulaten |
| JPS5756434A (en) * | 1980-09-22 | 1982-04-05 | Kao Corp | Stabilized foamable composition |
| US4678661A (en) * | 1983-09-28 | 1987-07-07 | Gerhard Gergely | Effervescent composition and method of making same |
| FR2593065B1 (fr) * | 1986-01-22 | 1988-09-09 | Smith Kline French Lab | Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation. |
| DE3627475A1 (de) * | 1986-06-26 | 1988-01-14 | Gergely Gerhard | Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung |
| US5064656A (en) * | 1989-11-14 | 1991-11-12 | Dr. Gergely & Co. | Uncoated pharmaceutical reaction tablet |
-
1992
- 1992-06-24 DK DK92912980.7T patent/DK0592484T3/da not_active Application Discontinuation
- 1992-06-24 ES ES92912980T patent/ES2053411T3/es not_active Expired - Lifetime
- 1992-06-24 CA CA002112663A patent/CA2112663C/fr not_active Expired - Fee Related
- 1992-06-24 WO PCT/EP1992/001421 patent/WO1993000886A1/fr not_active Ceased
- 1992-06-24 DE DE59201238T patent/DE59201238D1/de not_active Expired - Lifetime
- 1992-06-24 JP JP50191693A patent/JP3517233B2/ja not_active Expired - Fee Related
- 1992-06-24 AT AT92912980T patent/ATE117199T1/de active
- 1992-06-24 US US08/170,262 patent/US5415870A/en not_active Expired - Lifetime
- 1992-06-24 EP EP92912980A patent/EP0592484B1/fr not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993000886A1 (fr) | 1993-01-21 |
| CA2112663C (fr) | 2002-04-23 |
| US5415870A (en) | 1995-05-16 |
| CA2112663A1 (fr) | 1993-01-21 |
| ES2053411T1 (es) | 1994-08-01 |
| JPH06508839A (ja) | 1994-10-06 |
| ATE117199T1 (de) | 1995-02-15 |
| EP0592484A1 (fr) | 1994-04-20 |
| EP0592484B1 (fr) | 1995-01-18 |
| JP3517233B2 (ja) | 2004-04-12 |
| ES2053411T3 (es) | 1995-05-01 |
| DE59201238D1 (de) | 1995-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0592484T3 (da) | Brusetablet | |
| MY126736A (en) | 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof | |
| ATE305775T1 (de) | Tulobuterol enthaltendes präparat für perkutane absorption | |
| ATE163418T1 (de) | Risperidon pamoate | |
| DK0631575T3 (da) | Substituerede pyrimidiner samt deres anvendelse som fungicider | |
| UA19303A (uk) | Спосіб одержаhhя похідhих 2-аhіліhопіримідиhу | |
| CU22305A3 (es) | Procedimiento para la preparacion de un derivado de aminoacidos | |
| TR199903278T2 (en) | 2-Substit�te 4,5-Diaril imidazoller. | |
| DE69209323D1 (de) | Mehrschichttabletten mit gesteuerter wirkstoffabgabe enthaltend sowohl naproxen als auch naproxen natriumsalz | |
| KR950703327A (ko) | 씹을 수 있는 라니티딘 정제(Ranitidine Chewable Tablets) | |
| ATE140621T1 (de) | Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen wirkstoff, und verfahren zur herstellung | |
| DE59410151D1 (de) | Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe | |
| SE9401197D0 (sv) | Active compounds | |
| ATE180164T1 (de) | Brausemischung mit alkalisalzen oder lysinaten saurer, unlöslicher oder schwer löslicher wirkstoffe | |
| ATE165827T1 (de) | Herstellung von n-acetylneuraminsäure-derivaten | |
| SE8404841D0 (sv) | Brausegemisch, insbesondere fur brausetabletten, unter seiner verwendung hergestellte brausetabletten sowie verfahren zu seiner herstellung | |
| ATE10156T1 (de) | An elementen reiche zusammensetzung. | |
| DK0500851T3 (da) | Fremgangsmåde til fremstilling af et tablet- eller dragepræparat indeholdende en varme-, lys- og fugtfølsom aktiv bestanddel med en monoklin krystalstruktur | |
| MY110092A (en) | Butyric acid derivatives | |
| ATE64740T1 (de) | Platin enthaltender cytostatischer wirkstoff. | |
| DE69206102D1 (de) | Di(2-propyl)ester von 1-fluoro-2-phosphonomethoxy-3-p-toluol-sulfonyloxypropan, deren herstellung und vervendung. | |
| EP0337334A3 (fr) | Dérivés d'acides aminés inhibant la rénine | |
| ATE284309T1 (de) | Herstellung von brandschutzlaminaten | |
| ATE169021T1 (de) | Cephalostatin-analoga und ihre verwendung als antitumormittel | |
| KR900016130A (ko) | 2-피리딜메틸티오 유도체 및 궤양 치료제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |